The operating expenses of BioAge Labs, Inc. (BIOA) surged in Q4 2024 primarily due to an increase in channel expenses1.
This indicates that the company likely incurred higher costs related to its distribution channels, which could be a result of various factors such as increased marketing efforts, higher commission rates, or expanded sales force. Such expenses are crucial for the company's sales and revenue generation but can also significantly impact the overall profitability if not managed properly.